全文获取类型
收费全文 | 1335篇 |
免费 | 78篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 59篇 |
妇产科学 | 22篇 |
基础医学 | 196篇 |
口腔科学 | 12篇 |
临床医学 | 102篇 |
内科学 | 380篇 |
皮肤病学 | 13篇 |
神经病学 | 140篇 |
特种医学 | 23篇 |
外科学 | 78篇 |
综合类 | 3篇 |
一般理论 | 1篇 |
预防医学 | 57篇 |
眼科学 | 23篇 |
药学 | 137篇 |
中国医学 | 13篇 |
肿瘤学 | 164篇 |
出版年
2024年 | 4篇 |
2023年 | 10篇 |
2022年 | 21篇 |
2021年 | 44篇 |
2020年 | 31篇 |
2019年 | 33篇 |
2018年 | 37篇 |
2017年 | 29篇 |
2016年 | 29篇 |
2015年 | 35篇 |
2014年 | 54篇 |
2013年 | 60篇 |
2012年 | 85篇 |
2011年 | 102篇 |
2010年 | 47篇 |
2009年 | 49篇 |
2008年 | 77篇 |
2007年 | 79篇 |
2006年 | 91篇 |
2005年 | 97篇 |
2004年 | 103篇 |
2003年 | 67篇 |
2002年 | 65篇 |
2001年 | 10篇 |
2000年 | 10篇 |
1999年 | 12篇 |
1998年 | 14篇 |
1997年 | 8篇 |
1996年 | 8篇 |
1995年 | 10篇 |
1994年 | 9篇 |
1993年 | 4篇 |
1992年 | 11篇 |
1991年 | 8篇 |
1990年 | 8篇 |
1989年 | 6篇 |
1988年 | 4篇 |
1987年 | 3篇 |
1986年 | 3篇 |
1985年 | 3篇 |
1984年 | 9篇 |
1983年 | 4篇 |
1982年 | 4篇 |
1981年 | 7篇 |
1979年 | 2篇 |
1977年 | 4篇 |
1975年 | 3篇 |
1973年 | 2篇 |
1966年 | 2篇 |
1962年 | 1篇 |
排序方式: 共有1425条查询结果,搜索用时 31 毫秒
61.
Yoshiko Tomita Emma Hansson Florent Mazuir Gustaf J Wellhagen Qing Xi Ooi Enrica Mezzalana Atsushi Kitamura Daisuke Nemoto Sbastien Bolze 《CTS Clinical and Translational Science》2022,15(4):1014
Imeglimin is an orally administered first‐in‐class drug to treat type 2 diabetes mellitus (T2DM) and is mainly excreted unchanged by the kidneys. The present study aimed to define the pharmacokinetic (PK) characteristics of imeglimin using population PK analysis and to determine the optimal dosing regimen for Japanese patients with T2DM and chronic kidney disease (CKD). Imeglimin plasma concentrations in Japanese and Western healthy volunteers, and patients with T2DM, including patients with mild to severe CKD with an estimated glomerular filtration rate (eGFR) greater than 14 ml/min/1.73 m2 were included in a population PK analysis. PK simulations were conducted using a population PK model, and the area under concentration‐time curve (AUC) was extrapolated with power regression analysis to lower eGFR. The influence of eGFR, weight, and age on apparent clearance and of dose on relative bioavailability were quantified by population PK analysis. Simulations and extrapolation revealed that the recommended dosing regimen based on the AUC was 500 mg twice daily (b.i.d.) for patients with eGFR 15–45 ml/min/1.73 m2, and 500 mg with a longer dosing interval was suggested for those with eGFR less than 15. Simulations revealed that differences in plasma AUCs between Japanese and Western patients at the same dose were mainly driven by a difference in the eGFR and that the plasma AUC after 1000 and 1500 mg b.i.d. in Japanese and Western patients, respectively, was comparable in the phase IIb studies. These results indicate suitable dosages of imeglimin in the clinical setting of T2DM with renal impairment. Study Highlights
- WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC?
- WHAT QUESTION DID THIS STUDY ADDRESS?
- WHAT DOES THIS STUDY ADD TO OUR KNOWLEDGE?
- HOW MIGHT THIS CHANGE CLINICAL PHARMACOLOGY OR TRANSLATIONAL SCIENCE?
62.
63.
64.
Vitantonio Di Bello M.D. Enrica Talini M.D. Maria Grazia Delle Donne M.D. Fabrizio Aghini-Lombardi M.D. † Fabio Monzani M.D. ‡ Salvatore La Carrubba M.D. § Francesco Antonini-Canterin M.D. ¶ Frank Lloyd Dini M.D. # Giovanni Di Salvo M.D. Scipione Carerj M.D. †† Mario Marzilli M.D. 《Echocardiography (Mount Kisco, N.Y.)》2009,26(6):711-719
The new echocardiographic techniques for the study of physiopathological intramyocardial phenomena include video densitometry (VD), integrated backscatter (IBS), and color Doppler myocardial imaging (CDMI). Being more independent from cardiac load and from rotational and translational heart motion, these new sensible, noninvasive techniques such as CDMI and IBS show a real incremental value in comparison with conventional echocardiography and allow to detect subtle functional and textural abnormalities of intramural myocardium, partially undetectable by conventional two-dimensional Doppler echocardiography. Subclinical thyroid dysfunction (STD), both in its hypo- and hyperthyroidism form, has a relatively high prevalence in general population (9–15% with a lower percentage of adult males), hence it could be very useful to study more deeply heart involvement in these physiopathological conditions and understand the complex relationship between thyroid and heart. The use of these new ultrasonic techniques in subclinical hypothyroidism helps to detect the early simultaneous involvement of both cardiac cycle phases, which causes a decrease of intramyocardial contractility and an impairment of both active and passive phases of diastole. In subclinical hyperthyroidism, these new ultrasonic techniques permitted to discover more complex and different early cardiac abnormalities of both systolic and diastolic phases. 相似文献
65.
66.
M. Plebani D. Basso F. Navaglia M. De Paoli A. Tommasini A. Cipriani 《British journal of cancer》1995,72(1):170-173
In this study we compared the diagnostic utility of: (1) neuron-specific enolase (NSE); (2) squamous cell carcinoma antigen (SCC); (3) carcinoembryonic antigen (CEA); and (4) cytokeratin markers (CYFRA 21-1, TPA, TPM, TPS) in patients with small-cell lung cancer (SCLC) (21 cases) and non-small-cell lung cancer (94 cases). For comparison we also studied 66 patients with benign lung diseases and nine with pleural mesothelioma. NSE levels in SCLC patients were significantly higher than those in all the other groups studied. No significant variations were found among the SCC levels in all groups. CEA levels in patients with adenocarcinoma were significantly higher than those in all other groups studied. CYFRA 21-1 serum levels significantly increased in patients with squamous cell carcinoma and mesothelioma, while TPA, TPS and TPM increased in patients with lung cancer irrespective of the histological type. In patients with SCLC, high levels of all markers except SCC were found when the disease was extensive. In patients with non-SCLC, the highest levels of all tumour markers were usually found in those with advanced disease, although CYFRA 21-1 gave a sensitivity of 44% when a specificity of 95% was fixed in stage I non-SCLC patients. An analysis of receiver operating characteristic curves revealed that the highest diagnostic accuracies in distinguishing benign from malignant lung diseases were achieved with TPM (81%), CYFRA 21-1 (72%), CEA (78%) or TPA (78%) when using cut-off values of 46 Ul-1, 3.0 micrograms l-1, 2.0 micrograms l-1 and 75 Ul-1 respectively. When all patients were considered, the combined evaluation of more than one marker did not significantly improve the results obtained with TPM alone. However, taking into consideration the fact that CYFRA 21-1 is the most sensitive index of early lung tumours and that its combined determination with TPM did not worsen the overall sensitivity and specificity of the latter, the combined use of these two markers may be suggested as a useful took for the diagnosis of lung tumours. 相似文献
67.
68.
Ficarra R Tommasini S Raneri D Calabrò ML Di Bella MR Rustichelli C Gamberini MC Ficarra P 《Journal of pharmaceutical and biomedical analysis》2002,29(6):1005-1014
Flavonoids are natural substances with a lot of biological activities, including the antioxidant one. Their use in pharmaceutical field is, however, limited by their aqueous insolubility. As the formation of the inclusion complexes can improve their solubility in water, the flavonoids hesperetin, hesperidin, naringenin and naringin have been complexed with β-cyclodextrin (β-CD) by the coprecipitation method and studied in solution and in solid state by NMR, FT-IR, differential scanning calorimetry and X-ray techniques. The effects of complexation on the chemical shifts of the internal and external protons of β-CD in the presence of each flavonoid were observed. 相似文献
69.
Ficarra R Calabrò ML Cutroneo P Tommasini S Melardi S Semreen M Furlanetto S Ficarra P Altavilla G 《Journal of pharmaceutical and biomedical analysis》2002,29(6):799-1103
A rapid and sensitive RP-HPLC method with UV detection for routine control of oxaliplatin in a pharmaceutical formulation (Eloxatin®) was developed. Quantitation was accomplished with the internal standard method. The procedure was validated by linearity (correlation COEFFICIENT=0.999948), accuracy, robustness and intermediate precision. Experimental design was used during validation to calculate method robustness and intermediate precision. For robustness test three factors were considered: percentage v/v of acetonitrile, flow rate and temperature; an increase in the flow rate results in a decrease of the drug found concentration, while the percentage of organic modifier and temperature have no important effect on the response. For intermediate precision measure the considered variables were: analyst, equipment and days. The RSD value (2.27%, n=24) indicated a good precision of the analytical method. 相似文献
70.
The effects of silymarin on bronchoconstriction induced by antigen challenge and on post-antigen challenge hyperresponsiveness to substance P were evaluated in sensitized guinea-pigs. Silymarin significantly decreased the bronchoconstriction due to antigen administration in the early phase of the response. In contrast, the dose-response curve for substance P recorded 1 h after antigen challenge was not modified by pretreatment with silymarin. The influence of the flavonoid on hyperresponsiveness to histamine in propranolol- and PAF (platelet-activating factor)-treated animals was also assessed. Silymarin did not affect hyperresponsiveness to histamine induced by either propranolol or PAF although it had inhibitory activity on the bronchial contractile response to the autacoid. These results suggest that silymarin has a protective effect in the early phase of allergic asthma, an effect, which may be related to a negative influence of the flavonoid on bronchial responsiveness to histamine. 相似文献